Literature DB >> 21247164

Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphans.

Kejun Cheng1, Yong Sok Lee, Richard B Rothman, Christina M Dersch, Ross W Bittman, Arthur E Jacobson, Kenner C Rice.   

Abstract

Conformational restraint in the N-substituent of enantiomeric 5-(3-hydroxyphenyl)morphans was conferred by the addition of a cyclopropane ring or a double bond. All of the possible enantiomers and isomers of the N-substituted compounds were synthesized. Opioid receptor binding assays indicated that some of them had about 20-fold higher μ-affinity than the compound with an N-phenylpropyl substituent (K(i) = 2-450 nM for the examined compounds with various N-substituents). Most of the compounds acted unusually as inverse agonists in the [(35)S]GTP-γ-S functional binding assay using nondependent cells that stably express the cloned human μ-opioid receptor. Two of the N-substituted compounds with a cyclopropane ring were very potent μ-opioid antagonists ((+)-29, K(e) = 0.17 and (-)-30, K(e) =0.3) in the [(35)S]GTP-γ-S functional binding assay. By comparison of the geometry-optimized structures of the newly synthesized compounds, an attempt was made to rationalize their μ-opioid receptor affinity in terms of the spatial position of N-substituents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247164      PMCID: PMC3047451          DOI: 10.1021/jm1011676

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of Opioid Receptor affinity.

Authors:  Gianfranco Fontana; Giuseppe Savona; Benjamín Rodríguez; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano
Journal:  Tetrahedron       Date:  2008-12-20       Impact factor: 2.457

2.  Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.

Authors:  D Wang; K M Raehal; E J Bilsky; W Sadée
Journal:  J Neurochem       Date:  2001-06       Impact factor: 5.372

3.  Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.

Authors:  J B Thomas; S W Mascarella; R B Rothman; J S Partilla; H Xu; K B McCullough; C M Dersch; B E Cantrell; D M Zimmerman; F I Carroll
Journal:  J Med Chem       Date:  1998-05-21       Impact factor: 7.446

4.  Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonists.

Authors:  Kejun Cheng; In Jong Kim; Mei-Jing Lee; Steven A Adah; Tyler J Raymond; Edward J Bilsky; Mario D Aceto; Everette L May; Louis S Harris; Andrew Coop; Christina M Dersch; Richard B Rothman; Arthur E Jacobson; Kenner C Rice
Journal:  Org Biomol Chem       Date:  2007-03-01       Impact factor: 3.876

5.  Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay.

Authors:  H Xu; A Hashimoto; K C Rice; A E Jacobson; J B Thomas; F I Carroll; J Lai; R B Rothman
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

6.  Probes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-ols.

Authors:  Malliga R Iyer; Yong Sok Lee; Jeffrey R Deschamps; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice
Journal:  Bioorg Med Chem       Date:  2009-11-18       Impact factor: 3.641

7.  Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.

Authors:  Elliott J Sally; Heng Xu; Christina M Dersch; Ling-Wei Hsin; Li-Te Chang; Thomas E Prisinzano; Denise S Simpson; Denise Giuvelis; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Edward J Bilsky; Richard B Rothman
Journal:  Synapse       Date:  2010-04       Impact factor: 2.562

8.  Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomers.

Authors:  Muneaki Kurimura; Hehua Liu; Agnieszka Sulima; Akihiro Hashimoto; Anna K Przybyl; Etsuo Ohshima; Shinichi Kodato; Jeffrey R Deschamps; Christina M Dersch; Richard B Rothman; Yong Sok Lee; Arthur E Jacobson; Kenner C Rice
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

9.  Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphan.

Authors:  Akihiro Hashimoto; Arthur E Jacobson; Richard B Rothman; Christina M Dersch; Clifford George; Judith L Flippen-Anderson; Kenner C Rice
Journal:  Bioorg Med Chem       Date:  2002-10       Impact factor: 3.641

  9 in total
  5 in total

1.  Modulation of opioid receptor affinity and efficacy via N-substitution of 9β-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.

Authors:  Phong M Truong; Sergio A Hassan; Yong-Sok Lee; Theresa A Kopajtic; Jonathan L Katz; Aaron M Chadderdon; John R Traynor; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  Bioorg Med Chem       Date:  2017-03-01       Impact factor: 3.641

2.  Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor.

Authors:  Chunyang Jin; Ann M Decker; Xi-Ping Huang; Brian P Gilmour; Bruce E Blough; Bryan L Roth; Yang Hu; Joseph B Gill; X Peter Zhang
Journal:  ACS Chem Neurosci       Date:  2014-05-14       Impact factor: 4.418

3.  Cocaine dysregulates opioid gating of GABA neurotransmission in the ventral pallidum.

Authors:  Yonatan M Kupchik; Michael D Scofield; Kenner C Rice; Kejun Cheng; Bernard P Roques; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

4.  Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation.

Authors:  Tamara Antonio; Steven R Childers; Richard B Rothman; Christina M Dersch; Christine King; Martin Kuehne; William G Bornmann; Amy J Eshleman; Aaron Janowsky; Eric R Simon; Maarten E A Reith; Kenneth Alper
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

5.  Asymmetric C-H functionalization of cyclopropanes using an isoleucine-NH2 bidentate directing group.

Authors:  Jinhee Kim; Mikyung Sim; Namhoon Kim; Sungwoo Hong
Journal:  Chem Sci       Date:  2015-04-16       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.